Kim Lorence H. 4
4 · Revolution Medicines, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Kim Lorence H.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+16,700→ 16,700 totalExercise: $37.54Exp: 2034-06-19→ Common Stock (16,700 underlying) - Award
Common Stock
2024-06-20+4,800→ 70,500 total
Footnotes (2)
- [F1]Includes 9,175 Restricted Stock Units.
- [F2]Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.